INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Sep 18, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 8,611 | $20.80 | 55,840 |
| Sep 18, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 100 | $20.80 | 55,740 |
| Sep 18, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 1,200 | $20.95 | 54,540 |
| Sep 17, 2003 |
Director, Chief Exec Officer & President
Trans History: 442
|
Director, Chief Exec Officer & President | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 125,000 | $14.75 | 200,095 |
| Sep 17, 2003 |
Director, Chief Exec Officer & President
Trans History: 442
|
Director, Chief Exec Officer & President | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 88,007 | $20.95 | 112,088 |
| Sep 17, 2003 |
Director, Chief Exec Officer & President
Trans History: 442
|
Director, Chief Exec Officer & President | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 13,132 | $20.95 | 98,956 |
| Sep 17, 2003 |
Director, Chief Exec Officer & President
Trans History: 442
|
Director, Chief Exec Officer & President | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 125,000 | -- | -- |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 300 | $20.70 | 80,751 |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 5,000 | -- | -- |
| Sep 17, 2003 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 678
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 34,250 | -- | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.